MT Newswires Live09:56
Simcere Pharmaceutical Group (HKG:2096) posted an attributable net profit of 828.7 million yuan in the first half, up 37.9% from 601.1 million yuan a year ago.
Earnings per share came in at 0.32 yuan, up from 0.25 yuan a year earlier, according to a Friday filing with the Hong Kong Stock bourse.
Total revenue in the six months ended June 30 increased to 4.58 billion yuan from 3.59 billion yuan.
The company did not declare an interim dividend.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
